1st Quarter - Report

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS for AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Firm
Client
Income
—
Expenses
$20,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Prescription Drug Abuse Prevention - sharing the association's efforts to educate our members Sent comments to FDA in support of Pacira Pharmaceuticals, Inc.s application for EXPAREL to be used as a nerve block to produce regional anesthesia.

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

In support of the Protect Medical Innovation Act of 2017 (S 108/HR 184) - to repeal the medical device excise tax

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 184 (115th)

Health Issues HCR

In support of the RAISE Health Benefits Act (HR 1204) - expanding the use of FSAs In support of the Health Savings Act (HR 35) - expanding the use of HSAs In support of the Protecting Access to Care Act (HR 1215) - medical malpractice reform Comments to the FDA re: federal regulation of medical gases

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1215 (115th), H.R. 1204 (115th), H.R. 35 (115th)

Medicare/Medicaid MMM

In support of Repeal of the Protecting Seniors Access to Medicare Act to repeal the Medicare Independent Payment Advisory Board (S 260/HR 849) Advocating in support of changes to the enrollment requirement for the Medicare Part C and Part D programs for providers who are not otherwise required to enroll and who do not submit claims to Medicare.

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 849 (115th)

Insurance INS

In support of the Competitive Health Insurance Reform Act of 2017 (HR 372) - antitrust reform In support of legislation to require insurance coverage for patients with craniofacial anomalies. No bill introduced yet.

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 372 (115th)

Education EDU

In support of the Student Loan Refinancing Act (HR 1614) - would allow borrowers to refinance federal student loans In support of Employer Participation in Student Loan Assistance Act (HR 795) - would allow employers to receive a tax deduction for contributing to an employees student loan debt Also support the introduction of legislation that would: Allow interest free forbearance and/or deferment for loans in the internship/residency status of either payment delay option (HR 4001) Expand the student loan interest deduction Provide for scholarships for students going to practice medicine and dentistry in rural areas (HR 2574)

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4001 (115th), H.R. 2574 (115th), H.R. 1614 (115th), H.R. 795 (115th)

Medical/Disease Research/Clinical Labs MED

Advocating in support of increased NIH funding in the FY 2018 Labor-HHS-Education Appropriations bill.

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.